Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/51595| Title: | Library evidence report: Idarubicin and mitozantrone and cumulative lifetime doses of anthracyclines. | Authors: | Anderson, Alice | Monash Health Department(s): | Library Services | Databases used in the search strategy: | Ovid MEDLINE Ovid Embase |
Issue Date: | 17-Mar-2023 | Abstract: | This evidence report summaries the literature on the dose conversion factor of idarubicin and mitozantrone when calculating maximum lifetime cumulative doses of anthracyclines. | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/51595 | Type: | Evidence report | Temporal: | 1946-2023 | Audience: | This evidence report is only intended for use by Monash Health employees and researchers. |
| Appears in Collections: | Monash Health Library Evidence Reports |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| What is the dose conversion factor of idarubicin and mitozantrone - Literature Summary - 20230318_watermark (1)_organized.pdf | 906.46 kB | Adobe PDF | View/Open |
Page view(s)
60
checked on Jan 30, 2025
Download(s)
4
checked on Jan 30, 2025
Google ScholarTM
Check
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.